Skip to content

A

Agilent Technologies, Inc.

NYSE · Healthcare · Medical - Diagnostics & Research · US

$150.98
+0.67%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue7.4B6.9B6.5B6.8B6.8B
Cost of Revenue3.4B3.3B3.0B3.4B3.1B
Gross Profit4.0B3.6B3.5B3.5B3.7B
Operating Expenses
R&D Expense485.0M455.0M479.0M481.0M467.0M
SG&A Expense1.8B1.7B1.5B1.6B1.6B
General & Admin Expense
Selling & Marketing Expense
Other Expenses(7.0M)50.0M
Total Operating Expenses2.3B2.2B2.0B2.1B2.1B
Cost and Expenses5.7B5.5B5.0B5.5B5.2B
Operating Income (EBIT)1.6B1.5B1.5B1.4B1.6B
Non-Operating
Interest Income60.0M62.0M80.0M51.0M9.0M
Interest Expense106.0M112.0M96.0M95.0M84.0M
Net Interest Income(46.0M)(50.0M)(16.0M)(44.0M)(75.0M)
Other Non-Op Income/Expense19.0M(44.0M)33.0M(11.0M)(114.0M)
Non-Operating Income (excl Interest)(125.0M)(68.0M)(129.0M)(84.0M)30.0M
EBT (Pre-Tax Income)1.7B1.4B1.5B1.3B1.5B
Income Tax Expense218.0M132.0M232.0M99.0M250.0M
Bottom Line
Net Income1.4B1.3B1.3B1.2B1.3B
Earnings from Cont. Ops1.4B1.3B1.3B1.2B1.3B
Earnings from Discont. Ops
Bottom Line Net Income1.4B1.3B1.3B1.2B1.3B
Per Share
Basic EPS$5.09$4.59$4.44$4.22$4.19
Diluted EPS$5.08$4.57$4.43$4.19$4.18
Revenue Per Share$26.14$24.55$22.45$23.24$22.90
Shares
Basic Shares Outstanding282.0M283.0M290.0M294.0M299.0M
Diluted Shares Outstanding283.0M284.0M291.0M296.0M300.0M
Profitability Metrics
EBITDA2.0B1.8B1.9B1.7B1.9B
D&A205.0M288.0M257.0M271.0M317.0M
EBIT1.8B1.5B1.6B1.4B1.6B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jul 1, 2026